09-10, 07:00–08:00 (Europe/Istanbul), Young IFOS 2
Session Chair
Session Chair
Moderator-Speaker
Moderator-Speaker
<p>Pediatric otolaryngologist at Necker-Enfants Malades hospital in Paris, full professor at Université Paris Cité. Specialised in pediatric otology (cholesteatoma, vestibular diseases, CI) and skull base surgery with neurosurgical team. Fondamental research on the vestiular system in mouse models and children, with a focus on gene therapy and multi-sensory integration. Expertise in surgical education and simulation models (surgical videos, 3d-printing, virtual reality, OSATS) and deputy director of the school of surgery of Paris.</p>
This speaker also appears in:
- Juvenile angiofibroma management of residual disease
- Research outcomes in cholesteatoma
- Cochlear Implantation
- International Pediatric Balance Network (IPBN) Session Vestibular Testing in the Pediatric Population: New Indications and Approaches
- Skull base management in the child
- Management of unilateral hearing loss in children: a global perspective
- Elevate your ENT training: Tips and pearls
- Pediatric cholesteatoma follow-up, why is it different than adult?
- Cervical and facial congenital cysts
<p>Maryana Cherkes, MD, PhD, is an ENT Consultant at the Medical University of Graz, Austria, with clinical interests in rhinology, pediatric ENT, otology. In Austria since 2022 and has prior clinical experience in Lviv, Ukraine, including pediatric ENT and general surgery training. My research includes over 50 publications, a PhD on maxillary sinus anatomy, and ongoing projects in allergy, rhinology, and skull base surgery. Active in undergraduate and postgraduate teaching and has led major humanitarian and cochlear implantation initiatives in Ukraine.</p>
This speaker also appears in:
<p>Pavol Surda is a Consultant ENT and Rhinology Surgeon and the Clinical Lead for ENT at Guy’s and St Thomas’ Hospital, London. His clinical practice covers the full spectrum of nasal and sinus disease, with particular expertise in endoscopic sinus surgery, skull base surgery, and the management of sinonasal tumours.</p>
<p>He completed specialist fellowships in rhinology and facial plastics at St George’s University Hospital in London and anterior skull base surgery at the Academic Medical Centre in Amsterdam. He also holds a PhD from the University of Amsterdam, with award-winning research focused on “rhinitis in athletes”.</p>
<p>Pavol has a strong academic portfolio, having published over 80 peer-reviewed articles and book chapters. During the COVID-19 pandemic, he was among the first to describe anosmia as a presenting symptom and contributed to national tracheostomy service guidelines. His current interests include innovation in minimally invasive rhinology, use of technology in surgical planning, and robotic approaches to the skull base.</p>
<p>He is deeply involved in education and research, regularly teaching on international courses and contributing to national and European guidelines. He co-authored the Scott-Brown Essentials in Rhinology and is part of the SurgTech team, creating high-quality surgical training content.</p>
<p>Pavol is a member of the Executive Board of the European Rhinologic Society, Chair of the Young European ENT Confederation, and Honorary Secretary of the Laryngology & Rhinology Section at the Royal Society of Medicine.</p>
<p>A former elite triathlete, he brings the same discipline and pursuit of excellence to his clinical and academic work.</p>
This speaker also appears in:
<p>Dr. Pamuk completed his residency training in Otolaryngology in 2016 and is currently a faculty member in the Department of Otorhinolaryngology at Hacettepe University. His primary areas of clinical and research interest include head and neck surgical oncology, transoral laser and robotic surgery, and the application of artificial intelligence in head and neck oncology.</p>
This speaker also appears in:
- TORS for Oropharynx Squamous Cell Carcinomas
- Sentinel Lymph Node Excision for Oral Cavity Cancer
- Artificial Intelligence Applications in Laryngeal Cancer Modelling
- KNOWLEDGE AND ATTITUDES OF OTOLARYNGOLOGISTS REGARDING HUMAN PAPILLOMAVIRUS INFECTION AND VACCINATION
- Early-Stage Detection and Prevention of Head and Neck Cancers
- Artificial intelligence models for differantiation thyroid cancers
<p>Dr. Thomas Mayr, MD is an otolaryngologist affiliated with the Universitätsklinikum St. Pölten in Austria, where he works in the Division of Otorhinolaryngology. He is actively involved in clinical care and research focused on otology and implantable hearing solutions such as cochlear and other auditory implant.</p>